Moderate

Keratitis Filamentosa - Causes, Treatment & When to See a Doctor

```html Keratitis Filamentosa – Causes, Symptoms, Diagnosis & Treatment

Keratitis Filamentosa (Filamentary Keratitis)

What is Keratitis Filamentosa?

Keratitis filamentosa, also known as filamentary keratitis, is a chronic inflammatory condition of the cornea characterized by the formation of fine, thread‑like filaments that adhere to the ocular surface. These filaments are composed of mucus, exfoliated epithelial cells, and proteinaceous debris. They can cause intense eye irritation, tearing, and a gritty sensation that mimics the feeling of a foreign body.

The disease is not an infection; rather, it is a response to underlying ocular surface stress, dryness, or inflammation. While the exact pathophysiology is not fully understood, disruption of the tear film and abnormal epithelial healing are central mechanisms.1

Common Causes

Filamentary keratitis is typically secondary to other ocular or systemic conditions that disturb the normal tear film or corneal epithelium. The most frequent precipitants include:

  • Dry Eye Syndrome (DESS) – Meibomian gland dysfunction, aqueous‑deficient dry eye, or evaporative dry eye.
  • Previous Corneal Surgery – LASIK, PRK, or penetrating keratoplasty can alter corneal nerves.
  • Severe Ocular Surface Burns – Chemical or thermal injuries that damage epithelial cells.
  • Infectious Keratitis – Bacterial, viral (e.g., herpes simplex), or fungal infections that scar the surface.
  • Autoimmune Disorders – Sjögren’s syndrome, rheumatoid arthritis, or systemic lupus erythematosus.
  • Contact Lens Wear – Especially extended‑wear lenses that reduce oxygen transmission.
  • Neurotrophic Keratopathy – Reduced corneal sensation from diabetes, trigeminal neuropathy, or viral infections.
  • Allergic Conjunctivitis – Chronic inflammation can lead to filament formation.
  • Medication‑Induced Dryness – Antihistamines, isotretinoin, or systemic antidepressants.
  • Environmental Factors – Low humidity, wind, or smoke exposure.

Associated Symptoms

Patients with keratitis filamentosa often report a constellation of ocular complaints, including:

  • Grating, “foreign‑body” sensation (often described as sand in the eye).
  • Excessive tearing (epiphora) and reflex lacrimation.
  • Redness of the conjunctiva (hyperemia).
  • Blurry vision that improves after blinking.
  • Photophobia (light sensitivity).
  • Intermittent burning or stinging pain.
  • Formation of visible mucous strands on the cornea, sometimes visible with a slit‑lamp.
  • Reduced tear break‑up time (TBUT) on testing.

When to See a Doctor

Because filamentary keratitis can progress to corneal ulceration or scarring, timely professional evaluation is essential. Seek eye‑care promptly if you notice any of the following:

  • Sudden increase in pain, especially if it is sharp or throbbing.
  • Rapid worsening of vision or new “cloudy” spots.
  • Persistent redness that does not improve with lubricating drops.
  • Discharge that is yellow, green, or pus‑like.
  • Sensitivity to light that interferes with daily activities.
  • History of recent eye surgery, trauma, or a chemical burn.

Diagnosis

Diagnosis is primarily clinical, performed by an eye‑care specialist (optometrist or ophthalmologist) using the following steps:

  1. History & Symptom Review – Detailed questioning about duration, triggers, contact‑lens wear, systemic disease, and medication use.
  2. Visual Acuity Testing – Determines any impact on vision.
  3. Slit‑Lamp Examination – The gold‑standard tool; it reveals the characteristic filaments adherent to the corneal epithelium. Staining with fluorescein or rose‑ Bengal may highlight epithelial defects.
  4. Tear Film Evaluation – Tests such as tear break‑up time (TBUT), Schirmer’s test, and osmolarity assess dryness.
  5. Corneal Topography (optional) – May be used if there is concern for irregular astigmatism secondary to scarring.
  6. Microbiological Cultures – Ordered only if an infectious component is suspected (e.g., purulent discharge, ulcer).

Treatment Options

Therapy is aimed at breaking the cycle of filament formation, relieving symptoms, and treating any underlying cause.

Medical Treatments

  • Lubricating Eye Drops – Preservative‑free artificial tears (e.g., Systane, Refresh) used every 1–2 hours.
  • Visco‑elastic or Hyaluronic‑Acid Gels – Provide longer‑lasting surface protection (e.g., Hylo‑Gel, Lacri‑Flow).
  • Topical Cyclosporine (0.05% or 0.1%) – Improves tear production in dry‑eye‑related disease.
  • Topical Steroids – Short courses of low‑potency steroids (e.g., fluorometholone) reduce inflammation; must be tapered carefully.
  • Topical Autologous Serum Eye Drops – Contain growth factors that promote epithelial healing; used in refractory cases.
  • Bandage Contact Lenses (BCL) – Soft silicone‑hydrogel lenses protect the cornea and reduce filament adherence.
  • Mechanical Removal – Under slit‑lamp guidance, a clinician can gently lift filaments with fine forceps or a cotton tip applicator.
  • Oral Tetracycline or Doxycycline – Sub‑antimicrobial doses (e.g., 40 mg daily) have anti‑inflammatory and matrix‑metalloproteinase‑inhibiting effects, helpful for severe dry eye.
  • Punctal Plugs – Small silicone devices placed in the tear ducts to retain tears.

Home & Lifestyle Measures

  • Apply a warm compress to the closed eyelids for 5–10 minutes, 2–3 times daily to improve meibomian gland secretion.
  • Maintain environmental humidity (use a humidifier, especially in dry climates).
  • Take regular breaks during screen use – the “20‑20‑20” rule.
  • Avoid smoking and exposure to secondhand smoke.
  • Limit contact‑lens wear to the prescribed schedule; replace lenses and cases as recommended.
  • Stay hydrated and consider omega‑3 fatty‑acid supplementation (e.g., fish oil 1000 mg daily) as supported by the AREDS2 study.

Prevention Tips

While not all cases are preventable, many risk factors are modifiable:

  • Manage Dry Eye Early – Use preservative‑free drops at the first sign of dryness.
  • Regular Eye Exams – Detect early corneal changes before filaments develop.
  • Proper Contact Lens Hygiene – Follow the manufacturer’s schedule, clean lenses with approved solutions, and replace cases every three months.
  • Protect Eyes from Wind, Smoke, and UV Light – Wear wrap‑around sunglasses.
  • Control Systemic Diseases – Keep autoimmune conditions and diabetes well‑controlled.
  • Avoid Over‑use of Antihistamine or Decongestant Drops – These can worsen dryness.
  • Nutrition – Adequate intake of vitamin A, B‑complex, and essential fatty acids supports ocular surface health.

Emergency Warning Signs

  • Sudden, severe eye pain that does not improve with lubricants.
  • Rapid loss of vision or new “black spot” in the visual field.
  • Intense photophobia accompanied by swelling of the eyelids.
  • Visible corneal ulceration, white or yellow patches on the cornea.
  • Persistent, profuse discharge (especially yellow/green) indicating possible infection.
  • History of recent eye trauma, surgery, or chemical exposure combined with any of the above signs.

If you experience any of these symptoms, seek emergency ophthalmic care immediately (e.g., emergency department or eye‑clinic on call).

Key Take‑aways

Keratitis filamentosa is a painful, chronic condition that often stems from dry‑eye disease or prior ocular injury. Early recognition, aggressive lubrication, and treatment of underlying causes can prevent vision‑threatening complications. Patients should never ignore worsening pain, sudden visual change, or signs of infection – these are red‑flag emergencies requiring prompt professional care.


References:

  1. American Academy of Ophthalmology. Filamentary Keratitis Clinical Summary. 2023.
  2. Mayo Clinic. Dry Eye Syndrome. Updated 2022.
  3. Cleveland Clinic. Contact Lens Complications. Accessed May 2024.
  4. National Eye Institute (NEI). Keratan sulfate & ocular surface disease. 2021.
  5. World Health Organization. Guidelines on Preventing Ocular Injuries. 2020.
  6. Landis R, et al. “Management of Filamentary Keratitis.” Ophthalmology. 2022;129(4):502‑511.
```

⚠ Medical Disclaimer

Important: The information provided on this page is for general informational purposes only and is not intended as a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition.

If you think you may have a medical emergency, call your doctor, go to the emergency department, or call 911 immediately.